Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

80.26
Delayed Data
As of Sep 30
 +0.52 / +0.65%
Today’s Change
67.88
Today|||52-Week Range
88.48
-4.75%
Year-to-Date
7 Healthcare Stocks in Focus on World Heart Day
Sep 29 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Stock Higher, Upgraded at Goldman
Sep 27 / TheStreet.com - Paid Partner Content
Novo Nordisk Takes Axe to Workforce as Growth Falters
Sep 29 / TheStreet.com - Paid Partner Content
Analysts' Actions -- AutoZone, Eli Lilly, J.M. Smucker, Toll Brothers and More
Sep 27 / TheStreet.com - Paid Partner Content
Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health
Sep 29 / TheStreet.com - Paid Partner Content
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval
Sep 26 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Upgraded at Goldman, Jim Cramer Weighs In
Sep 27 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
Eli Lilly rises on Goldman recommendation
Sep 27 / FT.com - Paid Partner Content
Could This Alzheimers Disease Drug Really Be Worth $20 Billion?
Sep 19 / MotleyFool.com - Paid Partner Content
Eli Lilly Stock Upgraded: What You Need to Know
Sep 27 / MotleyFool.com - Paid Partner Content
Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
Sep 19 / Zacks.com - Paid Partner Content
Pfizer (PFE) to Stay Together as a Single Company After All
Sep 27 / Zacks.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content
Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep 27 / Zacks.com - Paid Partner Content
Surge in antidepressant use by children
Sep 08 / FT.com - Paid Partner Content
Biosimilars in Limelight on FDA Approval of Amgen Drug
Sep 27 / Zacks.com - Paid Partner Content
Novo Nordisk chief executive retires in shake-up
Sep 01 / FT.com - Paid Partner Content